4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-053667
President & CEO sold 40,000 shares at $60.15 ($2,405,872)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kurtz Ronald M MD President & CEO | 2024-05-03 | Sale 10b5-1 | −40,000 | $60.15 | $2,405,872 | 764,610 | I: show line 1 in the form |
| Open-market sales · 40,000 sh · avg $60.15 · $2,405,872 | |||||||
Loading xslF345X05/ownership.xml…